SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001640334-21-001618
Filing Date
2021-07-22
Accepted
2021-07-22 08:00:18
Documents
3
Period of Report
2021-07-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K skye_8k.htm 8-K 19230
2 EX-10.1 skye_ex101.htm EX-10.1 34195
3 EX-10.2 skye_ex102.htm EX-10.2 98922
  Complete submission text file 0001640334-21-001618.txt   153829
Mailing Address 5910 PACIFIC CENTER BLVD, SUITE 320 SAN DIEGO CA 92121
Business Address 5910 PACIFIC CENTER BLVD, SUITE 320 SAN DIEGO CA 92121 (949) 480-9051
Skye Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55136 | Film No.: 211106049
SIC: 2834 Pharmaceutical Preparations